BIO

Companies
Nyse American
Bio-Rad Laboratories Inc.
Health Care
Price Chart
Overview

About BIO

Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. It operates in two industry segments; In Clinical Diagnostics segment, the company manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In Life Sciences segment, the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with majority of the revenue being generated from United States, it also has its presence in Europe, Asia, Canada and other regions.

Market Cap
$8.2B
Volume
82.8M
Avg. Volume
89.4M
P/E Ratio
19.344637
Dividend Yield
0.00%
Employees
8.1K

Company Information

Exchange
Nyse American
Sector
Health Care
Industry
Medical Devices
Risk & Correlation Analysis
Market Correlation
0.82
Moderate Correlation
Volatility
Medium (0.36)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BIO.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BIO shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$8.2B
Volume82.8M
P/E Ratio19.34
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 14, 2025

PortfolioPilot Analysis

Get AI-powered insights on how BIO fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025